On March 23, 2015 the House Energy & Commerce Health Subcommittee convened a hearing titled Examining the 340B Drug Pricing Program. The goal of the hearing was to analyze the 340B program and hear from HRSA and related agencies.
Witnesses: (Copies of their testimony)
- Diana Espinosa, Deputy Administrator, Health Resources and Services Administration, U.S. Department of Health and Human Services
- Debbie Draper, Director, Health Care, Government Accountability Office
- Ann Maxwell, Assistant Inspector General for Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
Overall, the hearing was well-balanced. Several members were supportive of the program, while some raised concerns around transparency and the desire to directly track the savings. Based on comments from committee leadership, we should expect the subcommittee to continue to examine the program.
Association Contact: Amanda Cook, (202) 753-5328